Those taking GLP-1 medications lost just 5.3 percent on average
The long-term effects of use are unknown, and the quality of products available outside of research settings may vary substantially
GLP-1 Side Effects When GLP-1 binds to receptors in the brain, it signals the body to release a hormone called cholecystokinin (CCK)
1b), to provide an opportunity for activity at both incretin receptors
Peptides synthesised through rushed or outsourced manufacturing often contain truncated sequences, incorrect amino acid substitutions, or residual synthesis byproducts that make them more prone to aggregation during reconstitution
Recent post mortem studies revealed that GLP-1R expression was downregulated in the dorsal lateral prefrontal cortex and hippocampus of patients suffering from mood disorders, and those changes further correlated with an elevated body mass index (BMI) [79]